ROXADUSTAT (Evrenzo ®)

Clinical Indication

Symptomatic anaemia associated with chronic kidney disease (CKD) in adults

Date of classification

March 2022


Not yet reviewed drugs with no traffic light recommendation so not yet approved for use in LLR.

  • New medicines, devices, appliances.
  • New indication of existing medicine.
  • New NICE TA which has not been reviewed.
  • Not been requested for review by either TAS/LPT MMC.